›› 2015, Vol. 35 ›› Issue (7): 517-520.

• 基础研究 • 上一篇    下一篇

羟基磷灰石纳米颗粒对BMP-2的体外吸附和释放

许正元1,常阳阳2,伍翔1,谢广平3   

  1. 1. 浙江省长兴县中医院
    2. 湖州师范学院医学院
    3. 浙江省湖州市第一人民医院口腔科
  • 收稿日期:2015-01-05 修回日期:2015-03-01 出版日期:2015-07-28 发布日期:2015-08-04
  • 通讯作者: 许正元 E-mail:88581742@qq.com

The in vitro absorption and release kinetics of BMP-2 by hydroxyapatite nanoparticles

  • Received:2015-01-05 Revised:2015-03-01 Online:2015-07-28 Published:2015-08-04

摘要: [摘要] 目的 研究羟基磷灰石纳米颗粒(HANPs)对BMP-2的吸附和释放,探讨HANPs作为BMP-2药物载体的应用潜能。方法 采用Iodogen法对BMP-2进行125I标记,将HANPs分散于不同浓度的BMP-2溶液中,利用ITLC/SG对溶液进行展开,通过γ计数仪检测HANPs对BMP-2的吸附量。将吸附有BMP-2的HANPs(HANPs/125I-BMP-2)分散于生理盐水溶液中,15 d内每天利用ITLC/SG对溶液进行展开,通过γ计数仪检测BMP-2的释放量。结果 在BMP-2浓度为31.25~1 000 μg/mL时,HANPs对125I-BMP-2的吸附量与125I-BMP-2的浓度成正比,1 mg HANPs最高可吸附BMP-2达70 μg(70 μg/mg)。在15 d内, BMP-2能持续性从HANPs/125I-BMP-2释放,累计释放率能达到43%。结论 HANPs对BMP-2具有良好的体外吸附和释放效果,提示HANPs作为BMP-2的药物载体在骨组织工程具有极大应用潜能。

关键词: 羟基磷灰石纳米颗粒, 骨形成蛋白2, 药物载体, 125I标记

Abstract: Abstract: Objective To investigate the absorption and release kinetics of BMP2 by hydroxyapatite nanoparticles (HANPs),and to analyze the potential of HANPs as a carrier for drug delivery systems.Methods BMP2 was radiolabeled with 125I according to the Iodogen method.HANPs were dispersed in BMP2 solutions with different concentrations.The absorption of BMP2 onto HANPs was detected using ITLCSG and γcounter.A suspension of HANPs/125IBMP2 was prepared in normal saline and incubated at 37 ℃ for 15 days.On each day,the release kinetics of BMP2 from HANPs was detected using ITLCSG and γcounter too.Results When the concentrations of BMP2 solutions ranged from 31.251 000 μg/mL,the absorption rate and the concentration of 125IBMP2 were positively correlated,and the amount of 125IBMP2 absorbed onto HANPs could be as high as 70 μg/mg.The release profile showed sustained release of BMP2 during the period of the investigation and the release ratio could increase moderately to about 43%.Conclusions These results suggest that HANPs has the potential function as a carrier for drug delivery systems and a scaffold material for bone tissue engineering.

Key words: Hydroxyapatite nanoparticles, BMP-2, Drug carrier, 125I labeling

中图分类号: